27 Preoperative Preparation and Instruction

Kuniyoshi Yagyu and Ronald Shapiro

Summary

Safety is of upmost importance in hair transplantation, as many reports of unexpected complications are reported every year. Some unfortunately have involved fatal events in young patients. The author summarizes important issues on preoperative preparation and perioperative modifications for safe hair transplantation in patients with potentially problematic preexisting medical conditions. Treatment of actual emergency situation is discussed in Chapter 33. Some of the topics discussed are preoperative control of antithrombotic therapy in patients with coronary artery stents, atrial fibrillation, and mechanical heart valves. Other medical conditions that necessitate preoperative attention will also be addressed. Routine preoperative steps and instructions that help ensure a smooth procedure will also be discussed.

Schlüsselwörter

complication - hypertension - atrial fibrillation - NOAC - DOAC - DAPT - antithrombotic therapy - informed consent - coronary artery stent

• 1 Unger WP. Preoperative preparation and instructions. In: Unger WP, Shapiro R, Unger R, Unger M, eds. Hair Transplantation. 5th ed. New York, NY: Informa Healthcare; 2011:198–212

• 2 Lawrence C, Sakuntabhai A, Tiling-Grosse S. Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic surgical patients.. J Am Acad Dermatol 1994; 31 (6) 988-992 PubMed

• 3 Nelson JL. Conventional and nonconventional medications in hair transplantation. In: Unger WP, Shapiro R, Unger R, Unger M, eds. Hair Transplantation. 5th ed. New York, NY: Informa Healthcare; 2011:221–225

• 4 Black CE, Huang N, Neligan PC et al. Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature.. Am J Physiol Regul Integr Comp Physiol 2001; 281 (4) R1097-R1104 PubMed

• 5 Yagyu K. Peri-operative antithrombotic therapy in hair transplantation.. Hair Transpl Forum Int 2016; 26 (6) 241-251

• 6 Cryder B. A Practical review of the novel oral anticoagulants. Pharmd Bcacp. Available at: https://www.ipha.org/assets/docs/Locals/tableta%20practical%20review%20of%20the%20novel%20oral%20antico

• 7 Yagyu K. Safe surgery in patients with ischemic heart disease.. Hair Transpl Forum Int 2015; 25 (1) 28-32

• 8 Fleisher LA, Fleischmann KE, Auerbach AD et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.. Circulation 2014; 130 (24) e278-e333 PubMed

• 9 Levine GN, Bates ER, Bittl JA et al. 2016 ACC/AHA guidelines focused update on duration of dual antiplatelet therapy in patients with coronary artery disease; a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.. Circulation 2016; 134: e123-e155 PubMed

• 10 Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.. Circulation 2011; 123 (10) 1144-1150

• 11 . Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version.. Circ J 2010; 74 (11) 2479-2500 PubMed

• 12 Fuster V, Rydén LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.. Circulation 2011; 123 (10) e269-e367 PubMed

• 13 Doherty JU, Gluckman TJ, Hucker WJ et al. 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation. A report of the American College of Cardiology clinical expert consensus document task force.. J Am Coll Cardiol 2017; 69 (7) 871-898 PubMed

• 14 Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves.. N Engl J Med 2013; 369 (13) 1206-1214 PubMed

• 15 Nishimura RA, Otto CM, Bonow RO et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.. Circulation 2017; 135 (25) e1159-e1195

• 16 Vahanian A, Alfieri O, Andreotti F, et al. , , Guidelines on the management of valvular heart disease (version 2012) the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).. Eur J Cardiothorac Surg 2012; 42 (4) S1-S44 PubMed

• 17 Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation.. N Engl J Med 2015; 373 (9) 823-833 PubMed

• 18 Wedzicha JA, Miravitlles M, Hurst JR et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.. Eur Respir J 2017; 49 (3) 1600791 PubMed

• 19 Fleisher LA, Beckman JA, Brown KA et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.. Circulation 2009; 120 (21) e169-e276